NL7303437A - - Google Patents

Info

Publication number
NL7303437A
NL7303437A NL7303437A NL7303437A NL7303437A NL 7303437 A NL7303437 A NL 7303437A NL 7303437 A NL7303437 A NL 7303437A NL 7303437 A NL7303437 A NL 7303437A NL 7303437 A NL7303437 A NL 7303437A
Authority
NL
Netherlands
Application number
NL7303437A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7303437A publication Critical patent/NL7303437A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02Preparation
    • C07D501/04Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/21Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
NL7303437A 1972-03-13 1973-03-12 NL7303437A (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1169072A GB1425933A (en) 1972-03-13 1972-03-13 Cephalosporins

Publications (1)

Publication Number Publication Date
NL7303437A true NL7303437A (en:Method) 1973-09-17

Family

ID=9990907

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7303437A NL7303437A (en:Method) 1972-03-13 1973-03-12

Country Status (9)

Country Link
US (1) US3935204A (en:Method)
JP (1) JPS49290A (en:Method)
AT (1) AT334529B (en:Method)
CA (1) CA1037949A (en:Method)
CH (1) CH589094A5 (en:Method)
DE (1) DE2312042A1 (en:Method)
FR (1) FR2181810B1 (en:Method)
GB (1) GB1425933A (en:Method)
NL (1) NL7303437A (en:Method)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7401782A (en:Method) * 1973-02-14 1974-08-16
CA1088049A (en) * 1975-06-03 1980-10-21 Takashi Masugi 3-substituted-7-substituted alkanamido-3-cephem-4- carboxylic acid compounds and processes for preparation thereof
US4097670A (en) * 1976-04-05 1978-06-27 E. R. Squibb & Sons, Inc. Carboxyalkylureido cephalosporins
DE2760484C2 (en:Method) * 1976-04-14 1992-12-03 Takeda Chemical Industries, Ltd., Osaka, Jp
JPS5321192A (en) * 1976-08-10 1978-02-27 Takeda Chem Ind Ltd Cephalosporin derivatives and their preparation
US4086422A (en) * 1976-08-16 1978-04-25 E. R. Squibb & Sons, Inc. Carbamoylalkylureido cephalosporins
US4963542A (en) * 1976-09-08 1990-10-16 Takeda Chemical Industries, Ltd. Cephalosporin derivatives
US4124762A (en) * 1977-11-07 1978-11-07 Yeda Research And Development Co., Ltd. 7-[(Pyridylthiomethyl)phenyl]acetamido-cephalosporin derivatives
US4172942A (en) * 1977-11-21 1979-10-30 Yeda Research And Development Co. Ltd. 7-[(Substituted-thiomethyl)phenyl]acetamidocephalosporin derivatives
US4180661A (en) * 1977-11-25 1979-12-25 Yeda Research And Development Co. Ltd. 7-[(Substituted-isothioureamethyl)phenyl]-acetamidocephalosporin derivatives
US4217348A (en) * 1978-09-28 1980-08-12 E. R. Squibb & Sons, Inc. Cephalosporins having an oxazolidonyloxamido substituted acyl sidechain
US4486425A (en) * 1980-09-30 1984-12-04 Sankyo Company Limited 7-[2-(2-Aminothiazol-4-yl)-2-(syn)-methoxyiminoacetamido]-3-methoxymethyl-3-cephem-4-carboxylates
JPS5988490A (ja) * 1982-11-10 1984-05-22 Kyoto Yakuhin Kogyo Kk セフアロスポリン誘導体
WO1984001949A1 (en) * 1982-11-10 1984-05-24 Kyoto Pharma Ind Cephalosporin derivatives, process and their preparation, and prophylactic and treating agent against bacterial infection
FR2546520B1 (fr) * 1983-05-27 1985-08-30 Sanofi Sa Nouveaux composes antibiotiques derives des cephalosporines
JPS60218394A (ja) * 1984-04-16 1985-11-01 Takeda Chem Ind Ltd セフアロスポリンエステル誘導体
NZ208281A (en) * 1983-06-02 1986-11-12 Takeda Chemical Industries Ltd Cephalosporin ester derivatives and pharmaceutical compositions
JPS59225191A (ja) * 1983-06-02 1984-12-18 Takeda Chem Ind Ltd 経口用セフアロスポリン誘導体
FR2550200B1 (fr) * 1983-08-01 1988-04-08 Fujisawa Pharmaceutical Co Procede de preparation de composes de cephem a activite antimicrobienne et nouveaux produits ainsi obtenus
GB8400024D0 (en) * 1984-01-03 1984-02-08 Glaxo Group Ltd Cephalosporin antibiotics
US4914091A (en) * 1984-04-02 1990-04-03 American Cyanamid Company Esters of cephalosporin derivitives
CN103739618B (zh) * 2013-12-24 2016-08-31 深圳华润九新药业有限公司 头孢唑林酯及其制备方法、口服抗生素制剂
CN103755728B (zh) * 2013-12-24 2016-06-29 深圳华润九新药业有限公司 头孢唑林衍生物及其制备方法、口服抗生素制剂

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3692779A (en) * 1970-08-12 1972-09-19 Bristol Myers Co 7-{8 n-(substituted-imidoyl)aminoacetamide{9 cephalosporanic acids and derivatives thereof
US3873521A (en) * 1970-09-17 1975-03-25 Astra Laekemedel Ab Esters of {60 -amino penicillins
DE2228670A1 (de) * 1971-06-15 1973-01-11 Yamanouchi Pharma Co Ltd Neue oxymethylesterderivate von penicillin und cephalosporin
GB1335317A (en) * 1971-06-23 1973-10-24 Leo Pharm Prod Ltd Cephalosporin esters salts thereof and methods for their pre paration

Also Published As

Publication number Publication date
GB1425933A (en) 1976-02-25
AU5321373A (en) 1974-09-12
CA1037949A (en) 1978-09-05
ATA214173A (de) 1976-05-15
AT334529B (de) 1976-01-25
DE2312042A1 (de) 1974-01-03
FR2181810A1 (en:Method) 1973-12-07
US3935204A (en) 1976-01-27
FR2181810B1 (en:Method) 1976-12-31
JPS49290A (en:Method) 1974-01-05
CH589094A5 (en:Method) 1977-06-30

Similar Documents

Publication Publication Date Title
FR2181810B1 (en:Method)
JPS4976581A (en:Method)
IN140623B (en:Method)
JPS5216646Y2 (en:Method)
JPS5026437Y2 (en:Method)
JPS5125301Y2 (en:Method)
JPS4964314U (en:Method)
CS152723B1 (en:Method)
JPS4898690U (en:Method)
JPS4947580A (en:Method)
JPS4998102U (en:Method)
JPS4931374A (en:Method)
JPS4949931U (en:Method)
JPS48101512U (en:Method)
CH583718A5 (en:Method)
CH574603A5 (en:Method)
CH624272A4 (en:Method)
CH588154A5 (en:Method)
CH587841A5 (en:Method)
CH584195A5 (en:Method)
CH584180A5 (en:Method)
CH583223A5 (en:Method)
CH583042A5 (en:Method)
CH583036A5 (en:Method)
CH579967A5 (en:Method)

Legal Events

Date Code Title Description
BV The patent application has lapsed